| Code | CSB-YP4825MOV |
| Abbreviation | Recombinant Cynomolgus monkey GIPR protein, partial (Active) |
| MSDS | |
| Size | $9.9 |
| Promotion | |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
GIPR mediates the insulinotropic effects of glucose-dependent insulinotropic polypeptide and represents a validated target in metabolic disease research, yet reliable extracellular domain constructs for antibody screening remain scarce. This yeast-expressed fragment spanning residues 26–138 captures the N-terminal ligand-binding region and demonstrates quantifiable antibody recognition in functional ELISA, binding an anti-GIPR recombinant antibody with an EC50 of 12.66–13.86 ng/mL—a result that supports its use in therapeutic antibody epitope mapping, competitive inhibition assays, and blocking antibody screening campaigns. The construct carries an N-terminal 6xHis tag to facilitate oriented immobilization in surface plasmon resonance and biolayer interferometry experiments for affinity characterization of candidate biologics. Purity exceeding 95% by SDS-PAGE and endotoxin below 1.0 EU/μg align with standards expected in ligand-binding assays and antibody validation workflows where low background interference is critical.
There are currently no reviews for this product.